Smart Orthopedic Implants Market Report 2025

The smart orthopedic implants market size has grown strongly in recent years. It will grow from $24.57 billion in 2024 to $25.92 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth during the historic period can be attributed to the rising incidence of musculoskeletal disorders, an expanding elderly population, increased demand for minimally invasive surgical procedures, advancements in orthopedic surgical methods, and early adoption within well-established healthcare systems.

The smart orthopedic implants market size is expected to see strong growth in the next few years. It will grow to $31.77 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The anticipated growth in the forecast period can be credited to the expansion of remote patient monitoring capabilities, increasing demand for customized orthopedic treatments, greater adoption across emerging markets, a growing number of sports-related injuries, and an intensified focus on tracking postoperative outcomes. Key trends expected during this period include advancements in implant material technologies, ongoing innovation in sensor miniaturization, a rise in research and development partnerships, the integration of telehealth services with implant systems, and the development of cloud-based ecosystems for implant data management.

The increasing prevalence of musculoskeletal disorders is anticipated to drive the growth of the smart orthopedic implants market. Musculoskeletal disorders affect the bones, muscles, joints, tendons, and ligaments, often resulting in chronic pain and limited mobility. This rise in cases is linked to more sedentary lifestyles, which contribute to muscle weakening and joint strain as remote work and screen-based activities become more common. Smart orthopedic implants assist patients by providing real-time biomechanical feedback and early warning alerts, enhancing postoperative care and lowering the risk of revision surgeries. For example, in June 2024, the Australian Institute of Health and Welfare reported that around 7.3 million Australians, representing 29% of the population, were living with chronic musculoskeletal conditions. In 2022, these conditions contributed to 10,446 deaths, or 40 deaths per 100,000 people, accounting for 5.5% of total deaths that year. As a result, the growing burden of musculoskeletal disorders is contributing to the expansion of the smart orthopedic implants market.

Companies in the smart orthopedic implants sector are forming strategic partnerships to broaden their global reach and deliver more advanced patient care technologies. A strategic partnership involves a formal collaboration between two or more organizations that pool their resources, expertise, and innovation to achieve shared long-term goals, while continuing to operate independently. For example, in June 2025, NanoHive Medical LLC, a U.S.-based company specializing in 3D-printed spinal implants, partnered with DirectSync Surgical, a U.S.-based producer of human-powered smart implants. Together, they aim to develop Hive Soft Titanium spinal interbody fusion, a smart spine implant. This innovation integrates bone-stimulating and remote monitoring sensor technologies into NanoHive’s 3D-printed spinal fusion devices, utilizing a unique rhombic dodecahedron lattice to effectively channel energy from piezoelectric sensors. The collaboration is designed to enhance patient care through better data collection, bone stimulation, and connectivity with advanced surgical technologies and AI.

In February 2024, Exactech Inc., a U.S.-based medical device company, partnered with Statera Medical Inc. to advance precision in shoulder surgery. This collaboration seeks to co-develop the world’s first smart reverse shoulder implant by incorporating Statera’s Goldilocks smart implant technology into Exactech’s Equinoxe platform. The integration will allow surgeons to measure joint tension objectively and select implants more accurately, aiming to improve mobility, stability, and overall patient outcomes. Statera Medical Inc. is a Canada-based developer of smart orthopedic implants.

Major players in the smart orthopedic implants market are Johnson & Johnson, Medtronic plc, Medline Industries LP, Stryker Corporation, Zimmer Biomet Holdings Inc., Enovis Corporation, Orthofix Medical Inc., Exactech Inc., GPC Medical Ltd., Xenco Medical LLC, Heraeus Medical GmbH, Uteshiya Medicare, Intelligent Implants GmbH, Statera Medical Inc., SpineGuard SA, BoneTag Technologies, DirectSync Surgical Inc., AK Medical Holdings Limited, Bonebridge GmbH, and Mathys Ltd.

North America was the largest region in the smart orthopedic implants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in smart orthopedic implants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the smart orthopedic implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart orthopedic implants market consists of revenues earned by entities by providing services such as real-time data monitoring, postoperative recovery tracking, remote patient management, implant performance analytics, and early complication detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart orthopedic implants market also includes sales of smart elbow implants, smart finger joint implants, smart foot implants, smart hand implants, and smart jaw implants. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The smart orthopedic implants market research report is one of a series of new reports that provides smart orthopedic implants market statistics, including the smart orthopedic implants industry global market size, regional shares, competitors with the smart orthopedic implants market share, detailed smart orthopedic implants market segments, market trends, opportunities, and any further data you may need to thrive in the smart orthopedic implants industry. This smart orthopedic implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Smart orthopedic implants are advanced medical devices embedded with sensors and communication technologies that continuously monitor and transmit internal physiological data. They provide real-time insights into parameters such as load, pressure, temperature, and healing progression. These implants are designed to optimize recovery, enable early detection of complications, and tailor rehabilitation plans to improve the overall quality of patient care.

The primary categories of smart orthopedic implants include smart knee implants, smart hip implants, smart spine implants, smart shoulder implants, and smart ankle implants. Smart knee implants are sensor-equipped prosthetics that gather real-time data on motion and load, improving joint alignment, facilitating remote monitoring, and supporting post-surgical recovery. These implants are constructed from various materials, such as ceramic, metal, and polymer-based components, and incorporate several technologies like artificial intelligence, data analytics, microelectronic sensors, wearable integration, and telemedicine features. They are used across multiple applications including fracture fixation, joint replacement, osteotomy, and spinal fusion, and serve a range of healthcare facilities such as hospitals, ambulatory surgical centers, specialty clinics, and others.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.